Middle East & Africa Coagulant Market Size & Outlook
The coagulant market in Middle East & Africa is expected to reach a projected revenue of US$ 385.9 million by 2030. A compound annual growth rate of 5.3% is expected of Middle East & Africa coagulant market from 2024 to 2030.
Revenue, 2023 (US$M)
$268.3
Forecast, 2030 (US$M)
$385.9
CAGR, 2024 - 2030
5.3%
Report Coverage
Middle East & Africa
Middle East & Africa coagulant market, 2018-2030 (US$M)
MEA coagulant market highlights
- The MEA coagulant market generated a revenue of USD 268.3 million in 2023.
- The market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, systemic coagulants was the largest revenue generating product in 2023.
- Systemic Coagulants is the most lucrative product segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 268.3 million |
| Market revenue in 2030 | USD 385.9 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Systemic coagulants |
| Fastest growing segment | Systemic Coagulants |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Systemic Coagulants |
| Key market players worldwide | Johnson & Johnson, Baxter International Inc, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, Bayer AG, Novo Nordisk A/S ADR, CSL Ltd, Octapharma AG, Grifols SA Ordinary Shares - Class A, Amgen Inc, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.6% of the global coagulant market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,200.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Coagulant Market Scope
Coagulant market segmentation & scope
Application
Surgeries
Trauma Cases
Hemophilia
Bleeding Disorders
Other Applications
Route of Administration
Topical Administration
Parenteral Administration
Oral Administration
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Coagulant Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
